Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zoom reinforces commitment to AI literacy with national student learning experience
-
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
-
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook
-
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
-
New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal
-
Genius Group Sets ERL Share Count Date for February 13, 2026
-
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
-
Safe-Pro USA to Showcase New NIJ 0101.07 Government Certification-Ready High Performance Body Armor Plates & Innovative RAPID Series Ballistic Shield at SHOT Show 2026
-
Satellogic Signs $18MM USD Agreement with Portugal to Deliver Two Mark V High-Resolution Satellites
-
Cabaletta Bio Announces 2026 Strategic Priorities
-
Netcapital to Tokenize Hydrogen Drilling Assets
-
Zapata and University of Maryland Collaborate to Advance New Paradigm in Quantum Software
-
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
-
Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones
-
JFB Construction Holdings Announces Commencement of Vertical Construction at The Preserve at Port Salerno, Fla.
-
Abercrombie & Fitch Co. Provides Fourth Quarter and Fiscal Year Outlook Update
-
Pacific General Announces Strategic Investment in Old World Provisions
-
The Orchard, Queens and Long Island City’s Tallest Building by BLDG Management Co., Inc., Commences Leasing
-
Kratos Continues U.S. Defense Industrial Base Build Out with Expansion of Birmingham Operations with New 40,000-Square-Foot Facility
-
COMSTOCK RESOURCES, INC. ANNOUNCES FOURTH QUARTER 2025 EARNINGS DATE AND CONFERENCE CALL INFORMATION
-
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
-
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2
-
Gradalis Appoints Steven D. Weinstein as Chief Executive Officer
-
Breakthrough Study Shows Cognitive Training Improves Resilience for Warfighters
-
Wellcome Leap and Medicines360 Announce Partnership to Accelerate Development and Access to New Lifesaving Pregnancy and Stillbirth Risk-Reduction Tools for Women Worldwide
-
Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Milestone Payment Under Collaboratio
-
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
-
Schouw & Co. share buy-back programme, week 1+2 2026
-
Transactions in connection with share buyback programme
-
Rumble Secures Exclusive Video and Live Streaming Rights for The Dan Bongino Show
-
Toobit Lowers Entry Barriers with Risk-Free $100,000 Copy Trading Challenge
-
Independent Proxy Advisory Firms Recommend NuVista Shareholders Vote “For” Proposed Ovintiv Transaction
-
URBN Reports Record Holiday Sales
-
Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference
-
Figure Technology Solutions Reports Preliminary Q4 2025 & December Operating Data
-
The Chefs’ Warehouse Announces Preliminary Fiscal Year 2026 Guidance
-
Glenwood Springs Police Department Strengthens Non-Lethal Response Through Structured Training and Policy
-
Kelly Services Adopts Stockholder Rights Plan
-
Angitia Biopharmaceuticals Announces Dosing of First Participant in Phase 2 IDUN Trial of AGA2115 for the Treatment of Osteogenesis Imperfecta
-
Society Pass Incorporated, NusaTrip Incorporated and Bookcabin Announce Strategic Partnership to Expand Distribution in Projected US$115 Billion Indonesia Travel Market
-
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
-
FTI Consulting Expands Transactions Communications Capabilities with Two Senior Hires
-
Volatus to Participate in Investor Conferences and Comments on Shifting U.S. Defense Procurement Priorities
-
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
-
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
-
FuelCell Energy Appoints Amanda J. Schreiber as General Counsel and Corporate Secretary
-
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
-
KUSTOM ENTERTAINMENT, INC. COMPLETES THE DIVESTITURE OF ITS NOBILITY HEALTHCARE SUBSIDIARY; SHARPENS ITS FOCUS ON $100 BILLION LIVE ENTERTAINMENT AND ONLINE TICKETING MARKETS
-
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RN
-
XOMA Royalty Announces CFO Transition
